Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD

3.0283  -0.29 (-8.79%)

After market: 3.15 +0.12 (+4.02%)

Fundamental Rating

3

Taking everything into account, SNES scores 3 out of 10 in our fundamental rating. SNES was compared to 194 industry peers in the Pharmaceuticals industry. SNES has a bad profitability rating. Also its financial health evaluation is rather negative. SNES is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SNES had negative earnings in the past year.
SNES had a negative operating cash flow in the past year.
SNES had negative earnings in each of the past 5 years.
SNES had a negative operating cash flow in each of the past 5 years.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

SNES has a Return On Assets of -149.74%. This is amonst the worse of the industry: SNES underperforms 85.41% of its industry peers.
SNES has a Return On Equity of -182.47%. This is in the lower half of the industry: SNES underperforms 70.27% of its industry peers.
Industry RankSector Rank
ROA -149.74%
ROE -182.47%
ROIC N/A
ROA(3y)-106.9%
ROA(5y)-132.23%
ROE(3y)-129.16%
ROE(5y)-198.69%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

SNES has a better Gross Margin (50.15%) than 61.08% of its industry peers.
SNES's Gross Margin has improved in the last couple of years.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y17.7%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K

3

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SNES has more shares outstanding
SNES has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SNES is higher compared to a year ago.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K 500K
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -43.58, we must say that SNES is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -43.58, SNES is not doing good in the industry: 92.43% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.05 indicates that SNES is not too dependend on debt financing.
SNES has a Debt to Equity ratio (0.05) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -43.58
ROIC/WACCN/A
WACC9.7%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

SNES has a Current Ratio of 6.32. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 6.32, SNES is doing good in the industry, outperforming 71.35% of the companies in the same industry.
SNES has a Quick Ratio of 4.92. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SNES (4.92) is better than 66.49% of its industry peers.
Industry RankSector Rank
Current Ratio 6.32
Quick Ratio 4.92
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.67% over the past year.
The Revenue has grown by 37.58% in the past year. This is a very strong growth!
SNES shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.80% yearly.
EPS 1Y (TTM)84.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.33%
Revenue 1Y (TTM)37.58%
Revenue growth 3Y66.17%
Revenue growth 5Y31.8%
Sales Q2Q%33.89%

3.2 Future

SNES is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.59% yearly.
SNES is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.79% yearly.
EPS Next Y96.61%
EPS Next 2Y40.69%
EPS Next 3Y25.59%
EPS Next 5YN/A
Revenue Next Year61.35%
Revenue Next 2Y81.19%
Revenue Next 3Y80.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -10K -20K -30K -40K -50K

1

4. Valuation

4.1 Price/Earnings Ratio

SNES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNES is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

SNES's earnings are expected to grow with 25.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y25.59%

0

5. Dividend

5.1 Amount

No dividends for SNES!.
Industry RankSector Rank
Dividend Yield N/A

SENESTECH INC

NASDAQ:SNES (2/21/2025, 8:00:02 PM)

After market: 3.15 +0.12 (+4.02%)

3.0283

-0.29 (-8.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07
Inst Owners2.2%
Inst Owner Change-90.66%
Ins Owners0.02%
Ins Owner Change0%
Market Cap3.12M
Analysts82.86
Price Target10.2 (236.82%)
Short Float %3.81%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.11%
Min EPS beat(2)5.64%
Max EPS beat(2)36.58%
EPS beat(4)2
Avg EPS beat(4)-15.7%
Min EPS beat(4)-101.2%
Max EPS beat(4)36.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.01%
Min Revenue beat(2)-18.81%
Max Revenue beat(2)-7.22%
Revenue beat(4)0
Avg Revenue beat(4)-13.77%
Min Revenue beat(4)-23.89%
Max Revenue beat(4)-5.16%
Revenue beat(8)0
Avg Revenue beat(8)-23.6%
Revenue beat(12)0
Avg Revenue beat(12)-25%
Revenue beat(16)2
Avg Revenue beat(16)-16.02%
PT rev (1m)0%
PT rev (3m)-71.43%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-1400%
EPS NY rev (1m)0%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)-6.61%
Revenue NQ rev (3m)-6.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-17.78
EYN/A
EPS(NY)-6.36
Fwd EYN/A
FCF(TTM)-6.74
FCFYN/A
OCF(TTM)-6.63
OCFYN/A
SpS1.6
BVpS3.54
TBVpS3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -149.74%
ROE -182.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.15%
FCFM N/A
ROA(3y)-106.9%
ROA(5y)-132.23%
ROE(3y)-129.16%
ROE(5y)-198.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y17.7%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.23%
Cap/Sales 6.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.32
Quick Ratio 4.92
Altman-Z -43.58
F-Score4
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)79.38%
Cap/Depr(5y)58.63%
Cap/Sales(3y)15.27%
Cap/Sales(5y)27.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.33%
EPS Next Y96.61%
EPS Next 2Y40.69%
EPS Next 3Y25.59%
EPS Next 5YN/A
Revenue 1Y (TTM)37.58%
Revenue growth 3Y66.17%
Revenue growth 5Y31.8%
Sales Q2Q%33.89%
Revenue Next Year61.35%
Revenue Next 2Y81.19%
Revenue Next 3Y80.79%
Revenue Next 5YN/A
EBIT growth 1Y17.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.63%
EBIT Next 3Y16.45%
EBIT Next 5YN/A
FCF growth 1Y16.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.84%
OCF growth 3YN/A
OCF growth 5YN/A